NO995436L - Etylenglykolestere av monohydrobenzoporfyrin derivater som fotoaktive midler - Google Patents

Etylenglykolestere av monohydrobenzoporfyrin derivater som fotoaktive midler

Info

Publication number
NO995436L
NO995436L NO995436A NO995436A NO995436L NO 995436 L NO995436 L NO 995436L NO 995436 A NO995436 A NO 995436A NO 995436 A NO995436 A NO 995436A NO 995436 L NO995436 L NO 995436L
Authority
NO
Norway
Prior art keywords
ethylene glycol
glycol esters
photoactive agents
monohydrobenzoporphyrin
derivatives
Prior art date
Application number
NO995436A
Other languages
English (en)
Other versions
NO995436D0 (no
NO314264B1 (no
Inventor
Ethan Sternberg
David Dolphin
Julia G Levy
Anna M Richter
Elizabeth M Waterfield
David W C Hunt
Ashok Jain
Original Assignee
Qlt Phototherapeutics Inc
Univ British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Phototherapeutics Inc, Univ British Columbia filed Critical Qlt Phototherapeutics Inc
Publication of NO995436D0 publication Critical patent/NO995436D0/no
Publication of NO995436L publication Critical patent/NO995436L/no
Publication of NO314264B1 publication Critical patent/NO314264B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO19995436A 1997-05-07 1999-11-05 Etylenglykolestere av monohydrobenzoporfyrinderivater, anvendelse derav samt farmasöytisk blanding NO314264B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85249497A 1997-05-07 1997-05-07
PCT/CA1998/000468 WO1998050387A1 (en) 1997-05-07 1998-05-06 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents

Publications (3)

Publication Number Publication Date
NO995436D0 NO995436D0 (no) 1999-11-05
NO995436L true NO995436L (no) 2000-01-04
NO314264B1 NO314264B1 (no) 2003-02-24

Family

ID=25313492

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995436A NO314264B1 (no) 1997-05-07 1999-11-05 Etylenglykolestere av monohydrobenzoporfyrinderivater, anvendelse derav samt farmasöytisk blanding

Country Status (21)

Country Link
US (2) US5929105A (no)
EP (2) EP1177795B1 (no)
JP (1) JP3378889B2 (no)
KR (1) KR100397131B1 (no)
CN (1) CN1113882C (no)
AR (1) AR012673A1 (no)
AT (1) ATE211473T1 (no)
AU (1) AU741070B2 (no)
CA (1) CA2284879C (no)
CZ (1) CZ294715B6 (no)
DE (1) DE69803376T2 (no)
DK (1) DK0983273T3 (no)
ES (2) ES2171022T3 (no)
HK (1) HK1042439B (no)
HU (1) HU221754B1 (no)
IL (1) IL132066A (no)
NO (1) NO314264B1 (no)
NZ (1) NZ338031A (no)
PL (1) PL202341B1 (no)
PT (1) PT983273E (no)
WO (1) WO1998050387A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756396B1 (en) * 1997-05-07 2004-06-29 Qlt Inc. Ethylene glycol esters as photoactive agents
US6364907B1 (en) 1998-10-09 2002-04-02 Qlt Inc. Method to prevent xenograft transplant rejection
US6331235B1 (en) * 1998-12-11 2001-12-18 The University Of British Columbia Chiral separation of benzoporphyrin derivative mono-and di-acids by laser-induced fluorescence capillary electrophoresis
US6344050B1 (en) 1998-12-21 2002-02-05 Light Sciences Corporation Use of pegylated photosensitizer conjugated with an antibody for treating abnormal tissue
WO2000041726A2 (en) 1999-01-15 2000-07-20 Light Sciences Corporation Noninvasive vascular therapy
US6602274B1 (en) 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
US6454789B1 (en) 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
WO2000051638A1 (en) * 1999-02-26 2000-09-08 Qlt Phototherapeutics Inc. Photodynamic therapy in combination with apoptosis inducing factors
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
US6609014B1 (en) 1999-04-14 2003-08-19 Qlt Inc. Use of PDT to inhibit intimal hyperplasia
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20040208855A1 (en) * 1999-11-17 2004-10-21 Allison Beth Anne Use of PDT to inhibit intimal hyperplasia
US7122568B1 (en) 1999-11-17 2006-10-17 Qlt, Inc. Use of low-dose PDT to inhibit restenosis
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
US7282215B2 (en) 2000-05-08 2007-10-16 The University Of British Columbia Supports for photosensitizer formulations
CA2408323C (en) * 2000-05-08 2012-06-12 The University Of British Columbia Drug delivery systems for photodynamic therapy
EP1346059B1 (en) * 2000-11-29 2012-05-23 PCI Biotech AS Photochemical internalization for delivery of molecules into the cytosol
AU2210402A (en) * 2000-11-29 2002-06-11 Norwegian Radium Hospital Res Photochemical internalization for virus-mediated molecule delivery into the cyosol
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
JP2004532251A (ja) * 2001-05-31 2004-10-21 ミラヴァント ファーマシューティカルズ インコーポレイテッド 光線力学療法で使用のメタロテトラピロール系光増感剤
DE60230636D1 (de) * 2001-08-22 2009-02-12 Univ Montana State Porphyrine mit verbesserten multi-photonen-absorptionsquerschnitten für die photodynamische therapie
CA2466103C (en) * 2001-11-02 2010-06-15 The Governors Of The University Of Alberta Micelle compositions containing pegylated phospholipids and a photosensitizer
JP2005513001A (ja) 2001-11-09 2005-05-12 キュー エル ティー インク． 脱毛治療のための光力学療法
US7264629B2 (en) 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
CA2437638A1 (en) * 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
CA2457214A1 (en) * 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells
BR112012000254A2 (pt) 2009-07-08 2016-02-16 Dermira Canada Inc análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas.
JP5858932B2 (ja) 2010-02-04 2016-02-10 モルフォテック， インコーポレイテッド クロロトキシンポリペプチドおよびコンジュゲートならびにその使用
CA2824768A1 (en) 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
WO2013003507A1 (en) 2011-06-27 2013-01-03 Morphotek, Inc. Multifunctional agents
CA2853705C (en) 2011-10-25 2021-10-12 Memorial Sloan-Kettering Cancer Center Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
WO2014011875A1 (en) 2012-07-11 2014-01-16 Dermira, Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
EP2911666B1 (en) 2012-10-26 2022-08-24 Memorial Sloan-Kettering Cancer Center Modulators of resistant androgen receptor
EP3087182B1 (en) 2013-12-23 2019-03-20 Memorial Sloan-Kettering Cancer Center Methods and compositions for treating cancer using peptide nucleic acid-based agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283255A (en) * 1987-01-20 1994-02-01 The University Of British Columbia Wavelength-specific cytotoxic agents
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US5171749A (en) 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US4883790A (en) 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4920143A (en) * 1987-04-23 1990-04-24 University Of British Columbia Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents
CA2056431A1 (en) * 1989-06-07 1990-12-08 David Dolphin Photosensitizing diels-alder porphyrin derivatives
US5498710A (en) * 1994-04-22 1996-03-12 Health Research, Inc. Alkyl ether analogues of benzoporphyrin derivatives
HU224176B1 (hu) * 1997-05-07 2005-06-28 The University Of British Columbia A benzoporfirinszármazék fotoaktív vegyületek új osztálya

Also Published As

Publication number Publication date
CN1254339A (zh) 2000-05-24
DK0983273T3 (da) 2002-04-22
US6153639A (en) 2000-11-28
EP1177795A2 (en) 2002-02-06
NO995436D0 (no) 1999-11-05
WO1998050387A1 (en) 1998-11-12
HUP0003604A3 (en) 2002-04-29
IL132066A0 (en) 2001-03-19
NO314264B1 (no) 2003-02-24
US5929105A (en) 1999-07-27
PL336790A1 (en) 2000-07-17
HUP0003604A2 (hu) 2001-02-28
DE69803376D1 (de) 2002-02-28
IL132066A (en) 2008-06-05
CN1113882C (zh) 2003-07-09
AU7420798A (en) 1998-11-27
ES2171022T3 (es) 2002-08-16
NZ338031A (en) 2001-04-27
EP1177795A3 (en) 2002-05-29
EP0983273B1 (en) 2002-01-02
CA2284879A1 (en) 1998-11-12
PL202341B1 (pl) 2009-06-30
HU221754B1 (hu) 2002-12-28
ES2437790T3 (es) 2014-01-14
DE69803376T2 (de) 2002-08-14
HK1042439B (en) 2014-02-28
AR012673A1 (es) 2000-11-08
KR20010012331A (ko) 2001-02-15
KR100397131B1 (ko) 2003-09-13
JP3378889B2 (ja) 2003-02-17
EP0983273A1 (en) 2000-03-08
AU741070B2 (en) 2001-11-22
PT983273E (pt) 2002-06-28
EP1177795B1 (en) 2013-09-11
JP2001507369A (ja) 2001-06-05
ATE211473T1 (de) 2002-01-15
EP0983273B8 (en) 2002-10-09
CA2284879C (en) 2005-10-25
CZ392399A3 (cs) 2000-02-16
CZ294715B6 (cs) 2005-02-16

Similar Documents

Publication Publication Date Title
DK0983273T3 (da) Ethylenglycolestere af monohydrobenzoporphyrinderivater som fotoaktive midler
NO20013671D0 (no) Substituerte bicycliske derivater nyttige som anticancer midler
NO20002173D0 (no) Pleuromutilin-derivater som antimikrobielle midler
NO991557D0 (no) Anvendelse av alkansulfonsyrer som asfalten-dispergeringsmidler
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
NO20014412D0 (no) Forbindelser nyttige som anti-inflammatoriske midler
DK0823895T3 (da) Fedtsyreestere som bioaktive forbindelser
NO992725L (no) 6-Fenylpyridyl-2-amin-derivater anvendelige som NOS-inhibitorer
NO971137D0 (no) Dimetyl-(3-aryl-but-3-enyl)-aminforbindelse som farmasöytiske forbindelser
NO990435D0 (no) Fremstilling av estere som overflateaktive midler
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
NO20003105L (no) Fenylaminoalkylkarboksylsyre-derivater samt medisinske sammensetninger omfattende slike
NO20020457L (no) Benzenaminderivater som antikoagulanter
NO20001200D0 (no) Pyrrolopyrrolonderivater som inhibitorer av neurofil elastase
NO20000434D0 (no) Lyksofuranosyl benzimidazoler som antivirale midler
FI970727A0 (fi) Foerfarande och anordning foer torkning av objekt som innehaoller vatten
EE200000239A (et) Uued metüleenbisfosfoonhappe derivaadid
NO996244D0 (no) Pyrrolidinkarboksylsyrederivater som endotelinantagonister
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
DK0876367T3 (da) Trans apovincaminsyreesterderivater som lægemidler
NO20021249L (no) Tienoisoksazolfenoksyusubstituerte etyl- og propylderivater anvendbare som D4antagonister
NO307511B1 (no) Propenonderivater samt farmasøytisk sammensetning omfattende samme
NO965353D0 (no) 3-amino-2-okso-1-piperidineddiksyrederivater som enzyminhibitorer

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THE UNIVERSITY OF BRITISH COLUMBIA, CA

MM1K Lapsed by not paying the annual fees